Amyloid Fibrils: Formation, Polymorphism, and Inhibition.
暂无分享,去创建一个
[1] Yves F Dufrêne,et al. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. , 2009, The Biochemical journal.
[2] C. Dobson,et al. A clear view of polymorphism, twist, and chirality in amyloid fibril formation. , 2013, ACS Nano.
[3] B. Strooper,et al. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.
[4] Nikolaus Grigorieff,et al. Recent progress in understanding Alzheimer's β-amyloid structures. , 2011, Trends in biochemical sciences.
[5] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[6] D. Teplow,et al. Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.
[7] T. Härd,et al. Amyloid-β Protofibrils: Size, Morphology and Synaptotoxicity of an Engineered Mimic , 2013, PloS one.
[8] C. Dobson,et al. Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide. , 2014, ACS chemical biology.
[9] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[10] S. Hornemann,et al. The amyloid-Congo red interface at atomic resolution. , 2011, Angewandte Chemie.
[11] A. Wegner,et al. Fragmentation of actin filaments. , 1982, Biochemistry.
[12] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[13] Andrea Caporale,et al. Dissecting the Role of Single Regions of an IAPP Mimic and IAPP in Inhibition of Aβ40 Amyloid Formation and Cytotoxicity , 2011, Chembiochem : a European journal of chemical biology.
[14] J. Kelly,et al. Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics , 2003, Science.
[15] Mathias Jucker,et al. The Amyloid State of Proteins in Human Diseases , 2012, Cell.
[16] K. Sciarretta,et al. Peptide-based inhibitors of amyloid assembly. , 2006, Methods in enzymology.
[17] F. Ferrone,et al. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. , 1984, Biophysical journal.
[18] J. Weissman,et al. Amyloid structure: conformational diversity and consequences. , 2011, Annual review of biochemistry.
[19] Michele Vendruscolo,et al. Role of Intermolecular Forces in Defining Material Properties of Protein Nanofibrils , 2007, Science.
[20] P. Lansbury,et al. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.
[21] F. Heppner,et al. Evidence for age-dependent in vivo conformational rearrangement within Aβ amyloid deposits. , 2013, ACS chemical biology.
[22] C. Dobson,et al. Role of elongation and secondary pathways in S6 amyloid fibril growth. , 2012, Biophysical journal.
[23] Charles D. Schwieters,et al. Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.
[24] J. Hofrichter,et al. Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. , 1985, Journal of molecular biology.
[25] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.
[26] Ronald Wetzel,et al. Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.
[27] D. Frenkel,et al. Onset of heterogeneous crystal nucleation in colloidal suspensions , 2004, Nature.
[28] H. Nieznańska,et al. Cross-seeding of fibrils from two types of insulin induces new amyloid strains. , 2012, Biochemistry.
[29] Sara Linse,et al. Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. , 2014, Journal of the American Chemical Society.
[30] R. Tycko,et al. Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. , 2009, Biochemistry.
[31] Richard D. Leapman,et al. Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.
[32] Ruth Nussinov,et al. Selective molecular recognition in amyloid growth and transmission and cross-species barriers. , 2012, Journal of molecular biology.
[33] Michele Vendruscolo,et al. Systematic In Vivo Analysis of the Intrinsic Determinants of Amyloid β Pathogenicity , 2007, PLoS biology.
[34] T. Härd,et al. Inhibition of amyloid formation. , 2012, Journal of molecular biology.
[35] C. Dobson,et al. Sequestration of the Aβ Peptide Prevents Toxicity and Promotes Degradation In Vivo , 2010, PLoS biology.
[36] Michele Vendruscolo,et al. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.
[37] C. Dobson,et al. Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering , 2010, Proceedings of the National Academy of Sciences.
[38] Michele Vendruscolo,et al. Atomic structure and hierarchical assembly of a cross-β amyloid fibril , 2013, Proceedings of the National Academy of Sciences.
[39] David Eisenberg,et al. Atomic View of a Toxic Amyloid Small Oligomer , 2012, Science.
[40] L. Tjernberg,et al. Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.
[41] L. Lannfelt,et al. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. , 2007, ACS chemical biology.
[42] L. Kiessling,et al. Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. , 2001, Biochemistry.
[43] Sara Linse,et al. Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. , 2010, ACS chemical neuroscience.
[44] Hugo M. Botelho,et al. S100A6 Amyloid Fibril Formation Is Calcium-modulated and Enhances Superoxide Dismutase-1 (SOD1) Aggregation* , 2012, The Journal of Biological Chemistry.
[45] R. Tycko,et al. Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth. , 2013, Journal of the American Chemical Society.
[46] E. Goormaghtigh,et al. ATR-FTIR: a "rejuvenated" tool to investigate amyloid proteins. , 2013, Biochimica et biophysica acta.
[47] S. Radford,et al. Conformational Conversion during Amyloid Formation at Atomic Resolution , 2011, Molecular cell.
[48] John Collinge,et al. A General Model of Prion Strains and Their Pathogenicity , 2007, Science.
[49] Tuomas P. J. Knowles,et al. An Analytical Solution to the Kinetics of Breakable Filament Assembly , 2009, Science.
[50] G. Glenner,et al. X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[51] Steven M. Johnson,et al. Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses. , 2010, Current opinion in structural biology.
[52] A. Miranker,et al. Fiber-dependent amyloid formation as catalysis of an existing reaction pathway , 2007, Proceedings of the National Academy of Sciences.
[53] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.
[54] I. Graef,et al. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin , 2013, Proceedings of the National Academy of Sciences.
[55] S. Lindström,et al. Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides , 2007 .
[56] J. Kelly,et al. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.
[57] M. Benson,et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis , 2010, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[58] T. Härd,et al. Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation , 2008, Proceedings of the National Academy of Sciences.
[59] Jason T. Stevens,et al. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation , 2011, Nature.
[60] T. Härd. Protein engineering to stabilize soluble amyloid β‐protein aggregates for structural and functional studies , 2011, The FEBS journal.
[61] Jonathan S. Weissman,et al. The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.
[62] P. Westermark,et al. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] C. Dobson,et al. Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures , 2000 .
[64] Michele Vendruscolo,et al. Metastability of native proteins and the phenomenon of amyloid formation. , 2011, Journal of the American Chemical Society.